Frazier Management LLC Synlogic, Inc. Transaction History

Frazier Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 13, 2020	SELL	$1.96 - $2.81 $553,992 - $794,243	-282,649 Closed	0 $0
Q3 2019 Nov 12, 2019	SELL	$2.12 - $9.37 $1.24 Million - $5.46 Million	-582,758 Reduced 67.34%	282,649 $647,000
Q3 2018 Nov 14, 2018	BUY	$7.51 - $14.21 $329,929 - $624,273	43,932 Added 5.35%	865,407 $12.3 Million
Q2 2018 Aug 15, 2018	BUY	$9.01 - $13.33 $791,078 - $1.17 Million	87,800 Added 11.97%	821,475 $8.08 Million
Q1 2018 May 14, 2018	BUY	$9.38 - $12.12 $6.88 Million - $8.89 Million	733,675 New	733,675 $6.88 Million

25.5K

Ticker SYBX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 70,229,600
Market Cap $103M
Description
Synlogic, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of synthetic biotic medicines to treat metabolic and immunological diseases in the United States. Its therapeutic programs include SYNB1618 and SYNB1934 that are orally administered, non-systemically absorbed drug candidates, which are in Phase I...

Get notified when there are updates to the investment portfolio of Frazier Management LLC, based on Form 13F filings with the SEC.

Stay updated on Frazier Management LLC with notifications on news.